Avenue Therapeutics, Inc.
Pharmaceutical company · Bay Harbor Islands, Florida, United States · OTC: ATXI
Avenue Therapeutics, Inc. is a pharmaceutical company headquartered in Bay Harbor Islands, Florida, United States. Its earliest recorded incorporation is in 2015. Its shares trade on OTC under the ticker ATXI. It has reported private securities offerings to the US SEC, most recently $242,537 sold in a notice filed in 2023.
Avenue Therapeutics at a glance
What does Avenue Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $242,537 sold (2023).
Frequently asked questions about Avenue Therapeutics
Where is Avenue Therapeutics headquartered?
Avenue Therapeutics, Inc. is headquartered in Bay Harbor Islands, Florida, United States.
What does Avenue Therapeutics do?
Avenue Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Avenue Therapeutics a public company?
Yes. Avenue Therapeutics, Inc. trades on OTC under the ticker ATXI.
When was Avenue Therapeutics founded?
The earliest incorporation on record for Avenue Therapeutics, Inc. is in 2015, according to public company registers.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.